Allspring Global Investments’s Stoke Therapeutics STOK Stock Holding History

Allspring Global Investments’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$711K	Buy	21,739 +754	+4%	+$24.2K	﹤0.01%	1345
2026 Q1	$683K	Sell	20,985 -3,477	-14%	-$114K	﹤0.01%	1297
2025 Q4	$756K	Sell	24,462 -10,596	-30%	-$319K	﹤0.01%	1242
2025 Q3	$824K	Sell	35,058 -346	-1%	-$5.93K	﹤0.01%	1207
2025 Q2	$402K	Buy	+35,404	New	+$336K	﹤0.01%	1402
2023 Q4	–	Sell	-14,790	Closed	-$58.3K	–	2706
2023 Q3	$58.3K	Sell	14,790 -144	-1%	-$947	﹤0.01%	2210
2023 Q2	$159K	Sell	14,934 -214	-1%	-$2.28K	﹤0.01%	1885
2023 Q1	$126K	Sell	15,148 -152	-1%	-$1.37K	﹤0.01%	1960
2022 Q4	$141K	Buy	+15,300	New	+$159K	﹤0.01%	1943

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments's STOK Position: Q2 2026 in Review

Allspring Global Investments increased its Stoke Therapeutics (STOK) stake by 3.6% in Q2 2026, buying an estimated $24.2K and bringing the position to 21,739 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Allspring Global Investments first reported a position in STOK in Q4 2022 and has held it in 9 quarters since. The position peaked at $824K in Q3 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Allspring Global Investments held 21,739 shares of Stoke Therapeutics worth $711K as of Q2 2026.
Allspring Global Investments bought 754 Stoke Therapeutics shares in Q2 2026, an estimated $24.2K.
Stoke Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1345 holding.
Allspring Global Investments first reported a position in Stoke Therapeutics in Q4 2022 and has held it in 9 quarters since.
Allspring Global Investments's Stoke Therapeutics position peaked at $824K in Q3 2025.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.